Crypto exchange Kraken plans to offer prediction markets in 2026: CNBC Crypto World

Crypto exchange Kraken plans to offer prediction markets in 2026: CNBC Crypto World

ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email On today’s episode of CNBC Crypto World, Kraken’s global head of consumer, Mark Greenberg, discusses the crypto exchange’s recent announcement to acquire Backed Finance, the company driving the issuance of xStocks. Greenberg also discusses what can be expected from the crypto firm…

Read More
Former SEC chair Jay Clayton says regulators would scrutinize trading ahead of Trump post

Former SEC chair Jay Clayton says regulators would scrutinize trading ahead of Trump post

Jay Clayton said regulators would likely examine the unusual burst of trading activity early Monday that preceded a market-moving social media post from President Donald Trump. “Any move like that in advance of any announcement, the regulators are going to look at,” Clayton, a former chair of the Securities and Exchange Commission, said Wednesday on…

Read More
Government shutdowns usually have little economic impact. This time could be different

Government shutdowns usually have little economic impact. This time could be different

A view of the U.S. Capitol on September 29, 2025 in Washington, DC. Anna Moneymaker | Getty Images For all the political firestorms they generate, government shutdowns historically have been nonevents for both markets and the economy. This time, though, could be different. That’s because President Donald Trump’s threat to make some federal government furloughs…

Read More
Danaher is tapping the M&A well yet again. But we might have had enough

Danaher is tapping the M&A well yet again. But we might have had enough

Danaher ‘s days in the portfolio may be numbered. We’re again left disappointed after Danaher’s latest acquisition plan failed to inspire Wall Street. Shares of the life sciences giant lost more than 3.5% following Tuesday’s announcement that the company agreed to buy medtech Masimo for $180 per share in cash, or more than $9.6 billion. Masimo…

Read More